Med Discovery SA - Product Pipeline Review - 2014

Published: Aug, 2014 | Pages: 23 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Med Discovery SA - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Med Discovery SA - Product Pipeline Review - 2014', provides an overview of the Med Discovery SA's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Med Discovery SA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Med Discovery SA including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Med Discovery SA's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Med Discovery SA's pipeline products

Reasons to buy

- Evaluate Med Discovery SA's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Med Discovery SA in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Med Discovery SA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Med Discovery SA and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Med Discovery SA
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Med Discovery SA and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Med Discovery SA Snapshot 4
Med Discovery SA Overview 4
Key Information 4
Key Facts 4
Med Discovery SA - Research and Development Overview 5
Key Therapeutic Areas 5
Med Discovery SA - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Partnered Products 9
Partnered Products/Combination Treatment Modalities 10
Med Discovery SA - Pipeline Products Glance 11
Med Discovery SA - Clinical Stage Pipeline Products 11
Phase I Products/Combination Treatment Modalities 11
Med Discovery SA - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Med Discovery SA - Drug Profiles 13
MDPK-67b 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
MDP-01 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
MDRG-01 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Med Discovery SA - Pipeline Analysis 16
Med Discovery SA - Pipeline Products by Target 16
Med Discovery SA - Pipeline Products by Route of Administration 17
Med Discovery SA - Pipeline Products by Molecule Type 18
Med Discovery SA - Pipeline Products by Mechanism of Action 19
Med Discovery SA - Dormant Projects 20
Med Discovery SA - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 23
Disclaimer 23

List of Tables
Med Discovery SA, Key Information 4
Med Discovery SA, Key Facts 4
Med Discovery SA - Pipeline by Indication, 2014 6
Med Discovery SA - Pipeline by Stage of Development, 2014 7
Med Discovery SA - Monotherapy Products in Pipeline, 2014 8
Med Discovery SA - Partnered Products in Pipeline, 2014 9
Med Discovery SA - Partnered Products/ Combination Treatment Modalities, 2014 10
Med Discovery SA - Phase I, 2014 11
Med Discovery SA - Preclinical, 2014 12
Med Discovery SA - Pipeline by Target, 2014 16
Med Discovery SA - Pipeline by Route of Administration, 2014 17
Med Discovery SA - Pipeline by Molecule Type, 2014 18
Med Discovery SA - Pipeline Products by Mechanism of Action, 2014 19
Med Discovery SA - Dormant Developmental Projects,2014 20
Med Discovery SA, Other Locations 21